Schwab U.S. Dividend Equity ETF
SCHWAB STRATEGIC TRUST · Series S000034163 · 1 share classes
data updated 2026-09-08
Fund profile
As filed in the prospectus · 2025 Q4
The funds goal is to track as closely as possible, before fees and expenses, the total return of the Dow Jones U.S. Dividend 100 TM Index.
The fund tracks the Dow Jones U.S. Dividend 100 Index, which selects 100 high-dividend-yielding U.S. stocks with at least 10 consecutive years of dividend payments, chosen for fundamental strength based on cash flow to debt, return on equity, dividend yield, and five-year dividend growth. The fund generally replicates the index by holding the same securities at the same weights, though it may deviate to manage odd-lots, taxes, or liquidity. Because the fund may weight individual stocks differently from the index and may hold up to 10% of assets outside the index, its returns may diverge from the index's performance.
| Share class | Expense ratio |
|---|---|
| SCHD | 0.06% |
Portfolio turnover 30.00% · as of 2025 Q4
Allocation
Asset groups · long / short shown separately, never netted · 2026 Q2
| Stocks | 99.77% |
| Cash & short-term | 0.04% |
| Derivatives | 0.01% |
Derivatives are shown at market value, not notional exposure.
Latest quarter
What changed since the fund's previous filing
Return profile
Total return as filed — price change plus distributions reinvested · trailing figures to Apr 2026
May 2026 has been filed since the trailing figures were struck, so it is not in the table above or the curve — every figure here shares one cut-off, which is what makes them comparable with other funds.
Holdings
By % of NAV · equity positions carry filed share counts · every resolvable issuer links to its company page
| Ticker | Issuer | %NAV | Reported price | Value | Shares |
|---|---|---|---|---|---|
| QCOM | QUALCOMM IncQCOM | 6.74% | $251.02 | $6.40B | 25.5M |
| TXN | Texas Instruments IncTXN | 5.91% | $305.68 | $5.61B | 18.3M |
| UNH | UnitedHealth Group IncUNH | 5.09% | $380.31 | $4.84B | 12.7M |
| KO | The Coca-Cola CoKO | 3.96% | $79.01 | $3.76B | 47.5M |
| MRK | Merck & Co IncMRK | 3.86% | $118.72 | $3.66B | 30.9M |
| CVX | Chevron CorpCVX | 3.83% | $182.46 | $3.64B | 20.0M |
| VZ | Verizon Communications IncVZ | 3.65% | $47.81 | $3.47B | 72.5M |
| PG | The Procter & Gamble CoPG | 3.55% | $143.56 | $3.37B | 23.4M |
| COP | ConocoPhillipsCOP | 3.51% | $113.98 | $3.34B | 29.3M |
| AMGN | Amgen IncAMGN | 3.47% | $336.79 | $3.30B | 9.8M |
Reported price is the fund's own reported value divided by its own reported shares at 2026-05-31 — not a live quote, and not what the fund paid.
Top 10 positions are 43.57% of net assets, top 25 80.51%, across 102 issuers.
See more of this fund's book
More positions with filed share counts, and the quarter-over-quarter change list rather than the largest few — free with an account, no card required.
Sign in free